Meet-the-Professor Session:
81. HIV Resistance Testing
Friday, October 4, 2013: 7:00 AM-8:15 AM
Room: The Moscone Center: 270-276

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss viral resistance and resistance testing for HIV-infected patients
  • describe the selection of antiretroviral therapy with viral resistance

Target Audience: researchers, public health practitioners, members-in-training, infectious diseases physicians, infectious diseases pediatricians, HIV specialists, HIV clinicians, fellows, clinicians

Tracks: HIV-STD-TB

Meet-the-Professor:  Daniel Kuritzkes, MD, FIDSA, Brigham and Women's Hospital/Harvard Medical School


7:00 AM
Daniel Kuritzkes, MD, FIDSA

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-105-L02-P


D. Kuritzkes, Bristol-Myers Squibb: Consultant, Consulting fee
Celera: Consultant, Consulting fee
Gilead: Consultant, Investigator and Speaker, Consulting fee, Grant recipient and Speaker honorarium
Merck: Consultant and Investigator, Consulting fee and Grant recipient
Tobira: Consultant, Consulting fee
ViiV: Consultant and Speaker, Consulting fee and Speaker honorarium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.